Samah Aly Loutfy - Nanotechnology

Author Information

Samah Aly Loutfy is affiliated with the Nanotechnology Research Center (NTRC) at the British University in Egypt, located on the Suez Desert Road in El-Shorouk City, Cairo. Her work primarily focuses on nanotechnology applications in biomedical fields, including cancer research and the development of antiviral materials.

Research Contributions

Samah Aly Loutfy has made significant contributions to the field of nanotechnology, particularly in biomedical applications. Her research includes the development of zinc oxide nanoparticle-loaded electrospun polyvinylidene fluoride nanofibers for potential use as face protectors against respiratory viral infections. She has also explored the use of functionalized nanocarriers to manage glutathione (GSH) elevation and hypoxia in overcoming resistance to cancer therapies. Additionally, her work involves the molecular detection and genotyping of oncogenic viruses such as HPV, EBV, and HMTV among Egyptian breast cancer patients, as well as the investigation of BRCA1 and BRCA2 mutations and their clinical relevance.

Aliases

Samah Aly Loutfy is known by several aliases including Samah A. Loutfy, Samah A Loutfy, Samah Loutfy, and Sa Loutfy.

Publication and Citation Metrics

Metric	Value
Total Citation Count	980
H-index	18
Total Paper Count	73

Publications:

Zinc Oxide Nanoparticle-Loaded Electrospun Polyvinylidene Fluoride Nanofibers as a Potential Face Protector against Respiratory Viral Infections

DOI: 10.1021/acsomega.2c00458

Year: 2022

CMAR_A_294584 2835..2848

DOI:

Year: 2021

Recent advances in PVA-polysaccharide based hydrogels and electrospun nanofibers in biomedical applications: A review.

DOI: 10.1016/j.ijbiomac.2021.08.002

Year: 2021

Preparation of pyrimido[4,5-b][1,6]naphthyridin-4(1H)-one derivatives using a zeolite–nanogold catalyst and their in vitro evaluation as anticancer agent

DOI: 10.1177/1747519820988806

Year: 2021

Abstract 2512: BRCA1 and BRCA2 mutations and its clinical relevance among egyptian breast cancer women

DOI: 10.1158/1538-7445.AM2021-2512

Year: 2021

Presence of HPV, EBV and HMTV Viruses Among Egyptian Breast Cancer Women: Molecular Detection and Clinical Relevance

DOI: 10.2147/IDR.S313219

Year: 2021

Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers

DOI: 10.1016/j.jddst.2021.103022

Year: 2021

Abstract 2264: Molecular detection and genotyping of human papillomavirus in presence of some oncogenic viruses among Egyptian breast cancer women

DOI: 10.1158/1538-7445.AM2021-2264

Year: 2021

Prevalence of MMTV-Like env Sequences and Its Association with BRCA1/2 Genes Mutations Among Egyptian Breast Cancer Patients

DOI: 10.2147/CMAR.S294584

Year: 2021

Tioconazole and Chloroquine Act Synergistically to Combat Doxorubicin-Induced Toxicity via Inactivation of PI3K/AKT/mTOR Signaling Mediated ROS-Dependent Apoptosis and Autophagic Flux Inhibition in MCF-7 Breast Cancer Cells

DOI: 10.3390/ph14030254

Year: 2021

Why is Bio Distribution Important in Nanotechnology?

What are Programmable Cells?

How to Choose the Right Respiratory Protection?

How Does Surface Charge Density Affect Nanomaterials?

Why is Subthreshold Slope Important?

What is Fluorination?

What is Poly(N-isopropylacrylamide)?

How Does NIST Collaborate Internationally?

How Does RFID Nanotechnology Work?

What are Some Examples of Chemical Stimuli?

Partnered Content Networks

Relevant Topics